arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

STERIS plc

STE Health Care Industrial Specialties
$224.59
▼ -0.0% Today
as of Sep 4, 16:54 ET
Last 30 days -2.50% Jul 28 → Sep 04
$223.44 $227.60 $231.75 $235.90 $240.06 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$223.20
High
$225.44
Low
$221.44
Volume
$468,166
Avg Vol
$730,626
Mkt Cap
$23.0B
P/E (TTM)
57.59
Beta
—
52w High
$269.44
52w Low
$195.14
Div Yield
—
Shares Out
$98M

Recent Press Releases & News last 60 days · 25 items

Sep 4 · 15:30 Zacks
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
Sep 3 · 01:07 Simply Wall St.
STERIS (STE) Stock Looks Reasonable On Earnings With Cash Flow Slightly Stretched
Sep 2 · 05:22 Simply Wall St.
STERIS (STE) Could Be 12% Below Fair Value As Conference Focus Returns
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$195
$269
40% of range
Avg surprise (last 3)
+1.9%
Avg reaction (last 2)
-2.1%
0% positive
Latest IV / EM
25%
EM ±3.9% · $220 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.16$1.58$2.01$2.43$2.86 Actual $1.25Actual $1.16Actual $1.42Actual $1.46Actual $1.51Actual $1.75Actual $2.74Est $2.59Actual $2.34Est $2.32Actual $1.94Actual $1.96Actual $2.83Est $2.86 JunSepDecJunSepDecMar/2025Jun/2025SepDecMar/2026
Revenue vs Net Income Revenue Net income
$0$393M$786M$1.2B$1.6B Sep 24Dec 24Jun 25Sep 25Dec 25Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $2.83 $2.86 -1.1% +3.3% -2.7% earnings
Wed Dec 31, 2025Dec 2025 $1.96 — — — — financials
Tue Sep 30, 2025Sep 2025 $1.94 — — — — financials
Wed Aug 6, 2025Jun/2025 $2.34 $2.32 +0.9% — — earnings
Wed May 14, 2025Mar/2025 $2.74 $2.59 +5.8% — -1.6% earnings
Tue Dec 31, 2024Dec 2024 $1.75 — — — — financials
Mon Sep 30, 2024Sep 2024 $1.51 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.46 — — — — financials
Sun Dec 31, 2023Dec 2023 $1.42 — — — — financials
Sat Sep 30, 2023Sep 2023 $1.16 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.25 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1.49B—$1.50B$1.46B$1.39B—$1.37B$1.33B
Cost of revenue$809M—$841M$814M$763M—$760M$750M
Gross profit$684M—$656M$646M$628M—$610M$579M
Operating income$286M—$273M$266M$246M—$245M$220M
Net income$200M—$193M$192M$177M—$174M$150M
EPS (diluted)——$1.96$1.94$1.79—$1.75$1.51

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$482M$440M$424M$319M$280M$172M$155M$172M
Inventory$712M$632M$674M$658M$641M$581M$650M$689M
Total current assets$2.45B$2.39B$2.29B$2.11B$2.06B$2.00B$1.90B$1.94B
Total assets$10.74B$10.74B$10.59B$10.41B$10.40B$10.15B$10.01B$10.24B
Long-term debt$1.65B$1.81B$1.90B$1.90B$1.90B$1.92B$2.04B$2.16B
Total liabilities$3.51B$3.54B$3.42B$3.39B$3.44B$3.53B$3.58B$3.63B
Total equity$7.21B$7.18B$7.15B$7.02B$6.97B$6.60B$6.43B$6.61B

Implied volatility — last 90 days

20%35%49%64%79% Jun 08 — IV 29% · EM ±3.9%Jun 09 — IV 29% · EM ±3.7%Jun 10 — IV 29% · EM ±3.4%Jun 11 — IV 28% · EM ±3.1%Jun 12 — IV 29% · EM ±3.0%Jun 15 — IV 40% · EM ±2.9%Jun 16 — IV 39% · EM ±2.3%Jun 17 — IV 37% · EM ±1.6%Jun 19 — IV 26% · EM ±5.7%Jun 22 — IV 25% · EM ±5.3%Jun 23 — IV 26% · EM ±5.2%Jun 24 — IV 24% · EM ±4.7%Jun 25 — IV 24% · EM ±4.7%Jun 26 — IV 22% · EM ±4.2%Jun 29 — IV 25% · EM ±4.5%Jun 30 — IV 24% · EM ±4.2%Jul 01 — IV 26% · EM ±4.3%Jul 02 — IV 22% · EM ±3.6%Jul 03 — IV 23% · EM ±3.6%Jul 06 — IV 29% · EM ±4.1%Jul 07 — IV 27% · EM ±3.5%Jul 08 — IV 27% · EM ±3.4%Jul 09 — IV 23% · EM ±2.7%Jul 10 — IV 41% · EM ±4.6%Jul 13 — IV 34% · EM ±2.8%Jul 14 — IV 35% · EM ±2.5%Jul 15 — IV 39% · EM ±2.3%Jul 16 — IV 41% · EM ±1.7%Jul 20 — IV 33% · EM ±7.9%Jul 21 — IV 31% · EM ±7.3%Jul 22 — IV 34% · EM ±7.7%Jul 23 — IV 33% · EM ±7.3%Jul 24 — IV 34% · EM ±7.6%Jul 27 — IV 35% · EM ±7.3%Jul 28 — IV 32% · EM ±6.6%Jul 29 — IV 35% · EM ±7.0%Jul 30 — IV 35% · EM ±6.8%Jul 31 — IV 35% · EM ±6.7%Aug 03 — IV 39% · EM ±6.9%Aug 04 — IV 39% · EM ±6.7%Aug 05 — IV 41% · EM ±6.8%Aug 06 — IV 26% · EM ±4.2%Aug 07 — IV 22% · EM ±3.4%Aug 10 — IV 23% · EM ±3.2%Aug 11 — IV 24% · EM ±3.1%Aug 12 — IV 25% · EM ±3.1%Aug 13 — IV 24% · EM ±2.8%Aug 14 — IV 27% · EM ±3.0%Aug 17 — IV 28% · EM ±2.3%Aug 18 — IV 34% · EM ±2.5%Aug 19 — IV 30% · EM ±1.8%Aug 20 — IV 80% · EM ±3.3%Aug 24 — IV 22% · EM ±4.5%Aug 25 — IV 21% · EM ±4.3%Aug 26 — IV 20% · EM ±4.1%Aug 27 — IV 22% · EM ±4.4%Aug 28 — IV 22% · EM ±4.2%Aug 31 — IV 22% · EM ±3.9%Sep 01 — IV 22% · EM ±3.7%Sep 02 — IV 21% · EM ±3.5%Sep 03 — IV 22% · EM ±3.6%Sep 04 — IV 25% · EM ±3.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in